Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1369–1392 of 1,392 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Study Pill Clear all

Conditions: Diabetes Mellitus, Hypertension, Hyperlipidemia
Interventions: Pre-filled trays; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Healthy Controls
Interventions: Placebo pills for 14-day intervention, VVZ-2471 for 14-day intervention; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Chronic Disease
Interventions: Counseling, Flyer; Behavioral
Lead sponsor: Sutter Health; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Sleep Apnea, Obstructive
Interventions: Placebo pill, Trazodone; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Helicobacter Pylori
Interventions: Bismuth quadruple therapy with optimized proton pump inhibitor (PPI), Bismuth quadruple therapy with standard proton pump inhibitor (PPI), Clarithromycin triple therapy with optimized proton pump inhibitor (PPI), Clarithromycin triple therapy with standard PPI, Standard bismuth quadruple therapy; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: San Diego, California

Conditions: Anti-biotic Resistance
Interventions: Lactobacillus rhamnosus HN001, sugar pill (placebo); Dietary Supplement
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Menkes Disease
Interventions: Droxidopa Oral Product, Placebo Control; Drug · Other
Lead sponsor: Stephen G. Kaler; Other
Eligibility: 7 Years to 17 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: New York, New York

Conditions: Heavy Menstrual Bleeding
Interventions: Hysteroscopic myomectomy with Truclear, Medical therapy; Procedure · Drug
Lead sponsor: All For Women Healthcare, Illinois; Other
Eligibility: 21 Years to 80 Years · Female only
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: PURPURA
Interventions: Citrus Bioflavanoid Blend, Calcium Carbonate; Dietary Supplement
Lead sponsor: Nexgen Dermatologics, Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Boynton Beach, Florida

Conditions: Smoking Cessation
Interventions: Varenicline Tartrate, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: New Haven, Connecticut • Charleston, South Carolina

Conditions: Type 2 Diabetes
Interventions: MBX-102, Placebo, Actos; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 396 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 18
States / cities: Jonesboro, Arkansas • Buena Park, California • Los Angeles, California + 13 more

Conditions: Fecal Incontinence
Interventions: Clonidine, Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Anxiety
Interventions: 2 mg Melatonin, 10mg Melatonin, Placebo; Drug · Other
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 18 Years to 50 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 2
States / cities: San Diego, California • Portsmouth, Virginia

Conditions: Healthy
Interventions: Placebo, Meclizine; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Essential Thrombocythemia, Polycythemia Vera
Interventions: Ruxolitinib; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2034
U.S. locations: 4
States / cities: Boston, Massachusetts • Danvers, Massachusetts

Conditions: Obesity
Interventions: Behavioral Treatment, Placebo, Phentermine 15 MG; Behavioral · Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 21 Years to 70 Years
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hippocampal Overactivity, Dementia
Interventions: AGB101, Placebo; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hypertension, Hypertension Complicated
Interventions: RBPM, MII; Behavioral · Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 16,895 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 7
States / cities: Boston, Massachusetts • Quincy, Massachusetts • Roslindale, Massachusetts

Conditions: Chronic Obstructive Pulmonary Disease, Chronic Bronchitis
Interventions: Ivacaftor 150 MG, Placebo; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 40 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Breast Cancer
Interventions: Metformin, Placebo, Questionnaires, Sensory and Fine-Motor Tests; Drug · Other · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 74 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Healthcare Disparities, Reproductive Health, Sexual Health, Program Evaluation, Health Care Quality, Access, and Evaluation
Interventions: Complete Clinical Interaction; Other
Lead sponsor: Plan A Health, Inc; Other
Eligibility: Not listed
Enrollment: 10,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Gainesville, Florida • Saint Paul, Minnesota • Louise, Mississippi

Conditions: Ischemic Stroke
Interventions: donepezil, placebo; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Warren, Ohio • Pittsburgh, Pennsylvania

Conditions: Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer, Cancer of the Prostate
Interventions: Enzalutamide, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 1,401 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2025
U.S. locations: 37
States / cities: Tucson, Arizona • Los Angeles, California • Orange, California + 27 more

Conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Plasma Cell Leukemia, Myelodysplastic Syndromes, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-Cell Lymphoma, Prolymphocytic Leukemia, Lymphoblastic Lymphoma, Burkitt's Lymphoma, Non-Hodgkin's Lymphoma, Multiple Myeloma, Myeloproliferative Syndromes, Hematological Diseases
Interventions: Allopurinol, Fludarabine, Cyclophosphamide, ATG, TBI, Tacrolimus, MMF, Peripheral Blood Stem Cells, Related or Unrelated Bone Marrow Cells; Drug · Radiation · Biological
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: Up to 75 Years
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

Effects of Use of a Connected Pillbox On Medication Adherence

Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers

Family Planning Counseling for Women With Chronic Medical Conditions in an Inpatient Setting

The Effects of Trazodone on Sleep Apnea Severity

Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans

Impact of Probiotics for Reducing Infections in Veterans: The IMPROVE Study

NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease

Effectiveness of Truclear on Patient Quality of Life

A Novel Oral Natural Extract for the Treatment of Senile Purpura

Varenicline for Treatment of E-cigarette Dependence

Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin

A Placebo-Controlled Study of Clonidine for Fecal Incontinence.

Premedication With Melatonin in Lumbar Medial Branch Block Procedure

The Effects of Antihistamines on Pre-Pulse Inhibition

Ruxolitinib in Thrombocythemia and Polycythemia Vera

Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral Treatment

Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults

Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment

The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor

Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer

Evaluating the Mobile Clinic Model as a Means of Increasing Access to Reproductive and Sexual Health

Enhancing Rehabilitation After Stroke

Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

Allo HSCT Using RIC for Hematological Diseases